(Q44183258)

English

Drug-drug interactions in inmates treated for human immunodeficiency virus and Mycobacterium tuberculosis infection or disease: an institutional tuberculosis outbreak

scientific article published on 10 October 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Drug-drug interactions in inmates treated for human immunodeficiency virus and Mycobacterium tuberculosis infection or disease: an institutional tuberculosis outbreak (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Mycobacterium tuberculosis

0 references

1 reference

based on heuristic

inferred from title

drug interaction

0 references

8

object named as

Onorato I

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

author name string

Spradling P

1

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Drociuk D

2

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

McLaughlin S

3

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Lee LM

4

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Peloquin CA

5

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Gallicano K

6

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Pozsik C

7

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Castro KG

9

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Ridzon R

10

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

language of work or name

0 references

publication date

10 October 2002

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Clinical Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

35

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

1106-1112

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms.

1 reference

https://api.crossref.org/works/10.1086%2F343047

21 January 2018

A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1086%2F343047

21 January 2018

Improved survival among HIV-infected individuals following initiation of antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1086%2F343047

21 January 2018

Therapeutic implications of drug interactions in the treatment of human immunodeficiency virus-related tuberculosis

1 reference

https://api.crossref.org/works/10.1086%2F343047

21 January 2018

Treatment of HIV-related tuberculosis in the era of effective antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1086%2F343047

21 January 2018

Management of tuberculosis in the United States

1 reference

https://api.crossref.org/works/10.1086%2F343047

21 January 2018

A pharmacokinetic study of intermittent rifabutin dosing with a combination of ritonavir and saquinavir in patients infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1086%2F343047

21 January 2018

Use of rifabutin with protease inhibitors for human immunodeficiency virus-infected patients with tuberculosis

1 reference

https://api.crossref.org/works/10.1086%2F343047

21 January 2018

Using therapeutic drug monitoring to dose the antimycobacterial drugs

1 reference

https://api.crossref.org/works/10.1086%2F343047

21 January 2018

Pharmacokinetics of rifabutin

1 reference

https://api.crossref.org/works/10.1086%2F343047

21 January 2018

Rifabutin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy

1 reference

https://api.crossref.org/works/10.1086%2F343047

21 January 2018

Rifabutin absorption in humans: relative bioavailability and food effect

1 reference

https://api.crossref.org/works/10.1086%2F343047

21 January 2018

Impaired absorption of rifabutin by concomitant administration of didanosine

1 reference

https://api.crossref.org/works/10.1086%2F343047

21 January 2018

Antituberculosis drug-induced hepatotoxicity. The role of hepatitis C virus and the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1086%2F343047

21 January 2018

Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection

1 reference

https://api.crossref.org/works/10.1086%2F343047

21 January 2018

Hepatitis C and the correctional population

1 reference

https://api.crossref.org/works/10.1086%2F343047

21 January 2018

Increased mortality and tuberculosis treatment failure rate among human immunodeficiency virus (HIV) seropositive compared with HIV seronegative patients with pulmonary tuberculosis treated with "standard" chemotherapy in Kinshasa, Zaire

1 reference

https://api.crossref.org/works/10.1086%2F343047

21 January 2018

Increased recurrence of tuberculosis in HIV-1-infected patients in Kenya.

1 reference

https://api.crossref.org/works/10.1086%2F343047

21 January 2018

The impact of human immunodeficiency virus on mortality of patients treated for tuberculosis in a cohort study in Zambia

1 reference

https://api.crossref.org/works/10.1086%2F343047

21 January 2018

Identifiers

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44183258&oldid=2108322284"